» Articles » PMID: 2302697

Delivery of the Tumour Photosensitizer Zinc(II)-phthalocyanine to Serum Proteins by Different Liposomes: Studies in Vitro and in Vivo

Overview
Journal Cancer Lett
Specialty Oncology
Date 1990 Jan 1
PMID 2302697
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Zn-phthalocyanine (Zn-Pc) incorporated into liposomes of different phospholipids has been incubated in vitro with human serum and administered i.v. to rabbits. In both cases, chromatographic and density gradient ultracentrifugation studies indicate that Zn-Pc is almost exclusively bound by the 3 major lipoprotein components of the plasma (VLDL, LDL and HDL). The amounts of Zn-Pc recovered from the different lipoprotein fractions reflect their relative concentration in the serum. The presence of 20% moles of cholesterol in liposomes of dipalmitoyl phosphatidylcholine (DPPC) optimizes the release of Zn-Pc to LDL. This fact is important for enhancing the selectivity of drug delivery to tumors since LDL display a preferential interaction with neoplastic cells.

Citing Articles

Graphene Oxide/Cholesterol-Substituted Zinc Phthalocyanine Composites with Enhanced Photodynamic Therapy Properties.

Erden F Materials (Basel). 2023; 16(22).

PMID: 38004990 PMC: 10672206. DOI: 10.3390/ma16227060.


Application of Asymmetrical Flow Field-Flow Fractionation for Characterizing the Size and Drug Release Kinetics of Theranostic Lipid Nanovesicles.

Skupin-Mrugalska P, Elvang P, Brandl M Int J Mol Sci. 2021; 22(19).

PMID: 34638795 PMC: 8508677. DOI: 10.3390/ijms221910456.


Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells.

Obaid G, Jin W, Bano S, Kessel D, Hasan T Photochem Photobiol. 2018; 95(1):364-377.

PMID: 30125366 PMC: 6347486. DOI: 10.1111/php.13002.


Regulated necrosis in HeLa cells induced by ZnPc photodynamic treatment: a new nuclear morphology.

Soriano J, Villanueva A, Stockert J, Canete M Int J Mol Sci. 2014; 15(12):22772-85.

PMID: 25501332 PMC: 4284736. DOI: 10.3390/ijms151222772.


Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Castano A, Demidova T, Hamblin M Photodiagnosis Photodyn Ther. 2014; 2(2):91-106.

PMID: 25048669 PMC: 4108218. DOI: 10.1016/S1572-1000(05)00060-8.